Status:
Topic prioritisation
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

Criteria within the (VPAG) met as a new active substance. 

2024 voluntary scheme for branded medicines pricing, access and growth - GOV.UK 

ID number:
6549

Project Team

Project lead
Emily Richards

Email enquiries

If you have any queries please email scopingta@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
02 October 2025 Note - Note added to the project documents
04 March 2025 Topic selection

For further information on how we select topics for development, please see our page about topic prioritisation